Minervax: MinervaX and Wacker Biotech partner to scale up GBS vaccine production
MinervaX and Wacker Biotech announced yesterday that they have entered into a manufacturing agreement for MinervaXâs prophylactic vaccine against Group B Streptococcus infections.
Read full article »
Minervax is a Denmark-based biotechnology company that researches and develops maternal vaccines for the treatment of Group B streptococcus infections.
Read more